LDN Social Media
Get connected with us on social networks
LDN Community
Join our community here.
This is an excerpt from "Low-Dose Naltrexone Reduces Pain and Improves Function in Fibromyalgia"
By: Hibah Khaja, PharmD | Publish Date: November 10, 2025, Originally published in: Clinical Advisor - Rheumatology.
Low-dose naltrexone (LDN) significantly reduces pain and improves functional outcomes among patients with fibromyalgia while maintaining a favorable safety profile, according to study results presented at the American College of Rheumatology (ACR) Convergence 2025, held from October 24 to 29, in Chicago, IL.
For the full report, click the link below
https://www.clinicaladvisor.com/news/ldn-reduces-pain-and-improves-function-in-fibromyalgia/